Journal
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
Volume 17, Issue -, Pages 87-91Publisher
ELSEVIER
DOI: 10.1016/j.pdpdt.2016.11.010
Keywords
Photodynamic therapy; Relapsed or refractory mycosis fungoides; Aminolevulinic acid; Methyl aminolevulinic acid
Categories
Ask authors/readers for more resources
Mycosis fungoides is the most common cutaneous T-cell lymphoma. It is characterized by slow progress over years to decades, developing from patches to infiltrated plaques, and sometimes to tumors. Therapies such as localized chemotherapy, photochemotherapy and radiotherapy are often employed when lesions of refractory or relapsing mycosis fungoides are resistant to conventional therapies. However, these methods have acute or chronic side effects and toxicity, which may accumulate with repeated and protracted treatment cycles. Photodynamic therapy is a promising, well-tolerated option for the treatment of localized lesions with excellent cosmetic outcomes. In this article, we systematically reviewed and discussed clinical application of photodynamic therapy in relapsed or refractory mycosis fungoides. There are 20 papers included in this review article. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available